Top 5 stories on injectable HIV treatment and prevention from CROI 2021
Top 5 stories on HIV, ageing and co-morbidities from CROI 2021
Top 5 stories on HIV treatment and care in Africa from CROI 2021
São Paulo patient experiences apparent viral rebound a year and a half after stopping HIV treatment
‘Resilient’ HIV programmes in African countries have maintained viral suppression during the COVID-19 pandemic
What are the roles of TAF and integrase inhibitors in weight gain?
PrEP does not lower hormone levels in young transgender people, but lower PrEP levels seen in some transgender women
Four-days-on, three-days-off treatment regimen still looks effective after two years
Injectable HIV medications must be practical and affordable, conference hears
To be cost-effective, injectable PrEP can only cost about $3000 more than US generic oral PrEP
Gender-affirming surgery associated with sustained viral suppression
Doubling the dose of emergency contraception is a safe and effective way of overcoming efavirenz interaction
Every-other-month injectable cabotegravir and rilpivirine suppresses viral load for two years
Dolutegravir superior to standard-of-care treatment in children and adolescents
Targeted screening improves TB diagnosis in people with HIV in South Africa
Social networks key to PrEP uptake in rural Kenya and Uganda
People with HIV and hepatitis B should have ongoing monitoring for liver cancer
mRNA vaccine protects monkeys against HIV-like virus
